Cover Image
市場調查報告書

神經性疼痛:全球臨床實驗檢討

Neuropathic Pain Global Clinical Trials Review, H1, 2018

出版商 GlobalData 商品編碼 167075
出版日期 內容資訊 英文 618 Pages
訂單完成後即時交付
價格
Back to Top
神經性疼痛:全球臨床實驗檢討 Neuropathic Pain Global Clinical Trials Review, H1, 2018
出版日期: 2018年03月31日 內容資訊: 英文 618 Pages
簡介

本報告提供全球主要地區的神經性疼痛治療藥臨床實驗數和受驗人數,各階段趨勢,再加上主要企業和機關,臨床實驗簡介等。

簡介

  • 神經性疼痛
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區前五名國家的臨床實驗數量
    • 歐洲前五名國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國臨床實驗數量

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

參與神經性疼痛臨床實驗的主要企業

有潛力的藥劑

最新臨床實驗新聞

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Pfizer Inc.
    • AstraZeneca PLC
    • Grunenthal GmbH
    • GlaxoSmithKline plc
    • Eli Lilly and Company
    • NeurogesX, Inc.
    • GW Pharmaceuticals plc
    • Spinifex Pharmaceuticals Pty Limited
    • Endo International plc
    • AbbVie Inc.
  • 代表性的研究機關·醫院臨床實驗概要
    • UNIVERSITY HOSPITAL, CLERMONT-FERRAND
    • Lawson Health Research Institute
    • Rigshospitalet
    • Leiden University Medical Center
    • Danish Pain Research Center
    • Rambam Health Care Campus
    • University of Manitoba
    • University of California, San Francisco
    • U.S. Department of Veterans Affairs
    • Capital District Health Authority, Canada

5個代表性的臨床實驗簡介

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC4867CTIDB

GlobalData's clinical trial report, "Neuropathic Pain Global Clinical Trials Review, H1, 2018" provides an overview of Neuropathic Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Neuropathic Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • GlobalData Clinical Trials Report Coverage 6
  • Clinical Trials by Region 7
  • Clinical Trials and Average Enrollment by Country 8
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
  • Top Five Countries Contributing to Clinical Trials in Europe 11
  • Top Countries Contributing to Clinical Trials in North America 12
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
  • Top Five Countries Contributing to Clinical Trials in Central and South America 14
  • Clinical Trials by G7 Countries: Proportion of Neuropathic Pain to Central Nervous System Clinical Trials 15
  • Clinical Trials by Phase in G7 Countries 16
  • Clinical Trials in G7 Countries by Trial Status 17
  • Clinical Trials by E7 Countries: Proportion of Neuropathic Pain to Central Nervous System Clinical Trials 18
  • Clinical Trials by Phase in E7 Countries 19
  • Clinical Trials in E7 Countries by Trial Status 20
  • Clinical Trials by Phase 21
  • In Progress Trials by Phase 22
  • Clinical Trials by Trial Status 23
  • Clinical Trials by End Point Status 24
  • Subjects Recruited Over a Period of Time 25
  • Clinical Trials by Sponsor Type 26
  • Prominent Sponsors 27
  • Top Companies Participating in Neuropathic Pain Therapeutics Clinical Trials 28
  • Prominent Drugs 29
  • Latest Clinical Trials News on Neuropathic Pain 30
  • Mar 08, 2018: Aptinyx Presents Preclinical and Phase 1 Clinical Data on NYX-2925 at the 20th Annual Meeting of the American Society for Experimental Neurotherapeutics 30
  • Mar 06, 2018: Aptinyx Presents NYX-2925 Preclinical Data in Chemotherapy-induced Neuropathic Pain at the American Pain Society Annual Scientific Meeting 30
  • Jan 18, 2018: Biohaven Announces Initiation Of Clinical Development For BHV-5000, A Novel Low-Trapping NMDA Antagonist 30
  • Clinical Trial Profile Snapshots 32

Appendix 616

  • Abbreviations 616
  • Definitions 616
  • Research Methodology 617
  • Secondary Research 617
  • About GlobalData 618
  • Contact Us 618
  • Source 618

List of Tables

List of Tables

  • Neuropathic Pain Therapeutics, Global, Clinical Trials by Region, 2018* 7
  • Neuropathic Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
  • Neuropathic Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 9
  • Neuropathic Pain Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 10
  • Neuropathic Pain Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 11
  • Neuropathic Pain Therapeutics Clinical Trials, North America, Top Countries, 2018* 12
  • Neuropathic Pain Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2018* 13
  • Neuropathic Pain Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2018* 14
  • Proportion of Neuropathic Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2018* 15
  • Neuropathic Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16
  • Neuropathic Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17
  • Proportion of Neuropathic Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2018* 18
  • Neuropathic Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 19
  • Neuropathic Pain Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 20
  • Neuropathic Pain Therapeutics, Global, Clinical Trials by Phase, 2018* 21
  • Neuropathic Pain Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 22
  • Neuropathic Pain Therapeutics, Global, Clinical Trials by Trial Status, 2018* 23
  • Neuropathic Pain Therapeutics Clinical Trials, Global, by End Point Status, 2018* 24
  • Neuropathic Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 25
  • Neuropathic Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 26
  • Neuropathic Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 27
  • Neuropathic Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 28
  • Neuropathic Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 29

List of Figures

List of Figures

  • Neuropathic Pain Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
  • Neuropathic Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
  • Neuropathic Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 9
  • Neuropathic Pain Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 10
  • Neuropathic Pain Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 11
  • Neuropathic Pain Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 12
  • Neuropathic Pain Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2018* 13
  • Neuropathic Pain Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2018* 14
  • Proportion of Neuropathic Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2018* 15
  • Neuropathic Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16
  • Neuropathic Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17
  • Proportion of Neuropathic Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2018* 18
  • Neuropathic Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 19
  • Neuropathic Pain Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 20
  • Neuropathic Pain Therapeutics, Global, Clinical Trials by Phase (%), 2018* 21
  • Neuropathic Pain Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 22
  • Neuropathic Pain Therapeutics, Global, Clinical Trials by Trial Status, 2018* 23
  • Neuropathic Pain Therapeutics Clinical Trials, Global, by End Point Status, 2018* 24
  • Neuropathic Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 25
  • Neuropathic Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 26
  • Neuropathic Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 27
  • Neuropathic Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 28
  • Neuropathic Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 29
  • GlobalData Methodology 617
Back to Top